Publications of E. B. Binder

Gassen, N. C.; Hartmann, J.; Zannas, A. S.; Kretzschmar, A.; Zschocke, J.; Maccarrone, G.; Hafner, K.; Zellner, A.; Kollmannsberger, L. K.; Wag, K. V. et al.; Mehta, D.; Kloiber, S.; Turck, C. W.; Lucae, S.; Chrousos, G. P.; Holsboer, F.; Binder, E. B.; Ising, M.; Schmidt, M. V.; Rein, T.: FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY 21 (2), pp. 277 - 289 (2016)

Zannas, A. S.; Binder, E. B.: Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism. GENES BRAIN AND BEHAVIOR 13 (1), pp. 25 - 37 (2014)

Papst, L.; Binder, E. B.: How genes and environment interact to shape risk and resilience to stress-related psychiatric disorders. In: STRESS RESILIENCE: MOLECULAR AND BEHAVIORAL ASPECTS, pp. 197 - 207. ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD, 125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND (2020)

Zannas, A.; Jia, M.; Baumert, J.; Hafner, K.; Ködel, M.; Hähle, A.; Iurato, S.; Carrillo Roa, T.; Emeny, R.; Lathi, J. et al.; Raikkonen, K.; Eriksson, J.; Drake, A.; Waldenberger, M.; Wahl, S.; Kunze, S.; Lucae, S.; Bradley, B.; Gieger, C.; Hausch, F.; Smith, A.; Ressler, K.; Müller-Myhsok, B.; Ladwig, K.-H.; Rein, T.; Gassen, N.; Binder, E.: Aging- and Stress-Related Epigenetic Disinhibition of FKBP5 Contributes to NF-KB-Driven Inflammation and Cardiovascular Risk. 56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), Palm Springs, CA, December 03, 2017 - December 07, 2017. NEUROPSYCHOPHARMACOLOGY 42 (Suppl. 1), T26, pp. S310 - S311 (2017)

Mikoteit, T.; Wittwer, R.; Adamczyk, M.; Binder, E. B.; Steiger, A.; Hatzinger, M.; Zeising, M.: Prospective application of the rapid eye movement sleep derived biomarker prefrontal theta cordance improves treatment outcome of major depression. In JOURNAL OF SLEEP RESEARCH, 33. 27th Congress of the European-Sleep-Research-Society (ESRS), Seville, SPAIN, September 24, 2024 - September 27, 2024. (2024)

Narayan, S.; Roeh, S.; Czamara, D.; Miguel, P. M.; Alberry, B.; Silveira, P. P.; Schmidt, M.; Binder, E.: CHARACTERIZING SEX-SPECIFIC EFFECTS OF EARLY LIFE ADVERSITY ON THE ADULTHOOD BRAIN TRANSCRIPTOME USING A TRANSLATIONAL MOUSE MODEL. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 87, p. 103 - 103. World Congress of Psychiatric Genetics (WCPG), Singapore, SINGAPORE, October 15, 2024 - October 19, 2024. (2024)

Ramadan, A.; Calvano, C.; Buss, C.; Binder, E. B.; Winter, S. M.; Entringer, S.; Heim, C.: Refugee Children in Berlin: War and Migrationrelated Trauma and Biological Embedding. In PSYCHONEUROENDOCRINOLOGY, 160 Supplement Ed., p. 29. (2024)

Froehlich, A. S.; Gerstner, N.; Gagliardi, M.; Ködel, M.; Matosin, N.; Yusupov, N.; Murek, V.; Czamara, D.; Roeh, S.; Arloth, J. et al.; Ziller, M. J.; Binder, E. B.: CELL-TYPE SPECIFIC AGEING EFFECTS IN THE HUMAN ORBITOFRONTAL CORTEX AND IMPLICATIONS FOR PSYCHIATRIC DISEASE. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 75, pp. S25 - S26. World Congress of Psychiatric Genetics (WCPG), Montreal, CANADA, October 10, 2023 - October 14, 2023. (2023)

Hagenberg, J.; Binder, E. B.; Knauer-Arloth, J.: Multi-omics clustering of transdiagnostic cases reveals new depression subgroups and two subgroups of immune-related depression. In BRAIN BEHAVIOR AND IMMUNITY, 114, p. 34 - 34. 30th Annual Meeting of the PsychoNeuroImmunology-Research-Society (PNIRS), Boulder, CO, June 12, 2023 - June 15, 2023. (2023)

Karlbauer, V.; Czamara, D.; Martins, J.; Rex-Haffner, M.; Entringer, S.; Winter, S.; Buss, C.; Heim, C.; Binder, E. B.: TARGETED BISULFITE SEQUENCING REVEALS DRIVERS OF FKBP5 METHYLATION IN MALTREATED AND NON-MALTREATED CHILDREN. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 75, pp. S173 - S174. World Congress of Psychiatric Genetics (WCPG), Montreal, CANADA, October 10, 2023 - October 14, 2023. (2023)

Yusupov, N.; Dieckmann, L.; Erhart, M.; Sauer, S.; Rex-Haffner, M.; Kopf-Beck, J.; Brueckl, T.; Czamara, D.; Binder, E.: Transdiagnostic Evaluation of Epigenetic Age Acceleration and Burden of Psychiatric Disorders. In BIOLOGICAL PSYCHIATRY, 93 (9), p. S166 - S166. (2023)

Palma-Gudiel, H.; Marques Feixa, L.; Romero, S.; Rapado-Castro, M.; Blasco-Fontecilla, H.; Zorrilla, I.; Martin, M.; Quintas, A. C.; Monteserin-Garcia, J. L.; Font, E. et al.; Ramirez, M.; Moreno, D.; Marin-Vila, M.; Moreno, N.; Binder, E.; Fananas, L.: Children and adolescents exposed to maltreatment already exhibit epigenetic patterns suggestive of heightened low-grade inflammation. In EUROPEAN PSYCHIATRY, 65, p. S71 - S71. (2022)

Binder, E.: Has Clinical Translation of Scientific Research been a Failure? In EUROPEAN PSYCHIATRY, 65, pp. S6 - S7. (2022)

Gerstner, N.; Krontira, A.; Knauer-Arloth, J.; Binder, E. B.: Brain region specific effects on the expression of glucocorticoid receptor-regulated genes. In EUROPEAN JOURNAL OF HUMAN GENETICS, 30 (SUPPL 1), p. 301 - 301. (2022)

Fietz, J.; Pöhlchen, D.; Brueckl, T. M.; Padberg, F.; Binder, E. B.; Czisch, M.; Saemann, P.; Spoormaker, V. I.: Patient stratification based on pupillometric response profiles and its brain correlates in affective and anxiety disorders. In JOURNAL OF NEURAL TRANSMISSION, 128 (11), p. 1773 - 1773. (2021)

Binder, E.: EMBEDDING OF EARLY ADVERSITY, MOLECULAR MECHANISMS AND GENETIC MODERATION - IMPLICATIONS FOR RISK TRAJECTORIES IN PSYCHIATRY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 51, p. E2 - E2. (2021)

Dieckmann, L.; Cruceanu, C.; Lahti-Pulkkinen, M.; Kvist, T.; Lahti, J.; Sammallahti, S.; Graebig-Rancourt, R. C.; Plagemann, A.; Eriksson, J. G.; Kajantie, E. et al.; Braun, T.; Entringer, S.; Raikkonen, K.; Binder, E. B.; Czamara, D.: APPLICATION OF REFERENCE-BASED CELL TYPE ESTIMATION IN PLACENTAL TISSUE AND COMPARISON WITH A REFERENCE-FREE APPROACH FOR DNA METHYLATION STUDIES. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 51, pp. E216 - E217. (2021)

Martinelli, S.; Wiechmann, T.; Kathrin, H.; Meinhold, L.; Roeh, S.; Sauer, S.; Gassen, N.; Binder, E. B.: Unravelling the differential role of FKBP51 (FK506 Binding Protein 5) isoforms in different cellular pathways. In European Neuropsychopharmacology, 29, pp. S652 - S653. ECNP Workshop on Early Career Scientists in Europe, Nice, FRANCE, March 07, 2019 - March 10, 2019. Elsevier, Amsterdam (2019)

Arloth, J.; Eraslan, G.; Andlauer, T.; Gieger, C.; Gold, R.; Heilmann-Heimbach, S.; Kacprowski, T.; Meitinger, T.; Laudes, M.; Luessi, F. et al.; Mueller-Myhsok, B.; Nischwitz, S.; Peters, A.; Paul, F.; Rawal, R.; Strauch, K.; Wiendl, H.; Hemmer, B.; Theis, F.; Binder, E.; Mueller, N.: Identification of functionally relevant genetic variants associated with multiple sclerosis using deep learning. In MULTIPLE SCLEROSIS JOURNAL, 25, pp. 906 - 907. 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, SWEDEN, September 11, 2019 - September 13, 2019. (2019)

Athreya, A. P.; Neavin, D.; Carrillo-Roa, T.; Frye, M. A.; Skime, M.; Rush, A.; Bobo, W. V.; Wang, L.; Binder, E.; Iyer, R. K. et al.; Weinshilboum, R. M.: ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. In CLINICAL PHARMACOLOGY & THERAPEUTICS, 105, pp. S80 - S81. (2019)